MoneyWorks4Me

Lupin reports Profit after tax of Rs 3163.60 Mln, in the March 2021 quarter

13 May 2021 Evaluate
The total revenue for the quarter ended March 2021 remained nearly unchanged at Rs. 25159.60 millions.A good growth in profit of 40.42% reported to Rs. 3163.60  millions over Rs. 2252.90 millions of corresponding previous quarter.The company reported a good operating profit of 4911.20 millions compared to 4453.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202103 202003 % Var
Sales 25159.60 24838.80 1.29 110559.30 110256.60 0.27 110559.30 110256.60 0.27
Other Income 660.70 2099.10 -68.52 1290.90 4751.90 -72.83 1290.90 4751.90 -72.83
PBIDT 4911.20 4453.20 10.28 21731.50 23828.00 -8.80 21731.50 23828.00 -8.80
Interest 123.10 113.80 8.17 406.20 525.90 -22.76 406.20 525.90 -22.76
PBDT 4788.10 4339.40 10.34 21325.30 15710.00 35.74 21325.30 15710.00 35.74
Depreciation 1250.10 1247.80 0.18 5028.30 5187.50 -3.07 5028.30 5187.50 -3.07
PBT 3538.00 3091.60 14.44 16297.00 10522.50 54.88 16297.00 10522.50 54.88
TAX 374.40 838.70 -55.36 3710.80 3247.00 14.28 3710.80 3247.00 14.28
Deferred Tax 236.70 -263.20 -189.93 82.30 -373.50 -122.03 82.30 -373.50 -122.03
PAT 3163.60 2252.90 40.42 12586.20 7275.50 72.99 12586.20 7275.50 72.99
Equity 907.40 906.00 0.15 907.40 906.00 0.15 907.40 906.00 0.15
PBIDTM(%) 19.52 17.93 8.88 19.66 21.61 -9.05 19.66 21.61 -9.05
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..